D.E. Shaw & Co’s BioVie BIVI Stock Holding History

D.E. Shaw & Co’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-106	Closed	-$71K	–	5406
2021 Q3	$71K	Buy	+106	New	+$114K	﹤0.01%	4772

Other funds holding BIVI

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

swisspartners Vaduz, Liechtenstein $78.4M AUM 9.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

D.E. Shaw & Co's BIVI Position: Q4 2021 in Review

D.E. Shaw & Co sold out of BioVie (BIVI) in Q4 2021, closing a stake of 106 shares — an estimated $71K sold.

D.E. Shaw & Co first reported a position in BIVI in Q3 2021 and held it in 1 quarter. The position peaked at $71K in Q3 2021. 14 funds tracked by Wall St. Rank hold BIVI as of Q4 2021.

D.E. Shaw & Co reported no remaining BioVie position as of Q4 2021 after selling out during the quarter.
D.E. Shaw & Co sold 106 BioVie shares in Q4 2021, an estimated $71K.
D.E. Shaw & Co first reported a position in BioVie in Q3 2021 and held it in 1 quarter.
D.E. Shaw & Co's BioVie position peaked at $71K in Q3 2021.
14 funds tracked by Wall St. Rank held BioVie as of Q4 2021.

Based on D.E. Shaw & Co's 13F filing for Q4 2021, filed 14 Feb 2022.